A recent article published in BMJ explores the issue of the overuse of red blood cell (RBC) transfusions in stable non-bleeding patients. The article highlights that overuse puts patients at risk of harm, increases healthcare costs and threatens blood resources. Limited blood supplies for transfusion is a long-standing challenge, now amplified by the COVID-19 pandemic. The article provides recommendations to limit overuse of RBC transfusions, such as auditing, educating physicians, changing organizational policies, and using clinical decision support tools. Read the full article here.